Controlled Clinical TrialtaVNSn = 28
Feasibility of transcutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy
Wong ML, Widerström-Noga E, Bolanos JL, Gonzalez G, Penedo FJ, Hosein PJ, Tovin MM, Gonzalez JP, McTeague LM
Frontiers in Pain Research · 2024
Key finding
In a pilot sham-controlled trial in diabetic and chemotherapy-induced neuropathy, taVNS was well tolerated and partially reduced neuropathic tingling and pain with increased heart-rate variability.
- Condition
- Peripheral Neuropathy
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- 28
Cite this study
Wong, M. L., Widerström-Noga, E., Bolanos, J. L., Gonzalez, G., Penedo, F. J., Hosein, P. J., Tovin, M. M., Gonzalez, J. P., & McTeague, L. M. (2024). Feasibility of transcutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy. Frontiers in Pain Research, 5. https://doi.org/10.3389/fpain.2024.1516196
Summary by Vagus Research. Always consult the primary source for the authoritative record.